NEW
YORK, July 31, 2024 /PRNewswire/ -- The
global smart inhaler technology market size is estimated to
grow by USD 46.37 million from
2023-2027, according to Technavio. The market is estimated to grow
at a CAGR of almost 10.16% during the forecast period. Rising
prevalence of respiratory diseases is driving market
growth, with a trend towards availability of real-time
feedback. However, low product penetration in developing
countries poses a challenge. Key market players include
3M Co., Adherium Ltd., Amiko Digital
Health Ltd., AptarGroup Inc., AstraZeneca Plc, Cognita Labs, Cohero
Health Inc., Findair Sp. Z o. O., Infineon Technologies AG,
Novartis AG, OPKO Health Inc., ResMed Inc., Sensirion AG, Teva
Pharmaceutical Industries Ltd., and Vectura Group plc.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click
for the snapshot of this report
Forecast
period
|
2023-2027
|
Base Year
|
2022
|
Historic
Data
|
2017 - 2021
|
Segment
Covered
|
Product (Inhalers and
Nebulizers), Application (Asthma and COPD), and Geography (North
America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
3M Co., Adherium Ltd.,
Amiko Digital Health Ltd., AptarGroup Inc., AstraZeneca Plc,
Cognita Labs, Cohero Health Inc., Findair Sp. Z o. O., Infineon
Technologies AG, Novartis AG, OPKO Health Inc., ResMed Inc.,
Sensirion AG, Teva Pharmaceutical Industries Ltd., and Vectura
Group plc
|
Key Market Trends Fueling Growth
Smart inhaler technology provides real-time feedback to users,
enhancing the effectiveness of their inhaler usage and respiratory
health management. This immediate information and guidance help
optimize inhaler technique for maximum medication delivery to the
lungs. Real-time adherence tracking allows users to promptly adjust
behavior if they miss a dose. Some smart inhalers offer real-time
environmental information, enabling informed decisions about
activities and locations. Personalized guidance based on inhalation
patterns improves medication efficacy. Real-time alerts and
reminders enhance adherence to treatment plans. Smart inhalers
detect changes in usage patterns or symptoms, preventing
exacerbations. Real-time insights empower users to take control of
their respiratory health, driving the growth of the smart inhaler
market.
The Smart Inhaler Market is experiencing significant growth due
to the rising prevalence of chronic respiratory diseases like
asthma. Connected medical devices, such as those produced by Planet
Innovation, are revolutionizing the industry with offerings like
HeroTracker Sense. These smart inhalers, which can be Metered Dose
Inhalers (MDI) or Dry Powder Inhalers (DPI), are transforming how
patients manage their conditions. Hospital pharmacies, retail
pharmacies, and online pharmacies are embracing this technology to
improve patient care. Hospitals and home care settings are also
adopting smart inhalers to reduce hospital admissions, patient
visits, and respiratory complications. Technological advancements,
including digital technology and sensors, enable real-time clinical
data collection. Smart inhalers, which can be used in highly
polluted areas, ensure proper drug dosage and medicinal adherence.
The aging population base, tobacco smoke, and air pollution are
driving demand for these devices. Telemedicine and e-commerce
platforms are further expanding access to smart inhalers. With
disposable incomes on the rise, patients are investing in digital
devices for preventive care. Smart inhalers have shown positive
procedural outcomes for acute respiratory diseases. Bluetooth
connectivity allows seamless integration with smartphones and
digital devices, making treatment measures more convenient and
effective. The market is expected to grow as more people seek
advanced solutions for respiratory ailments.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Smart inhalers, innovative devices with limited market
penetration in developing countries, face impediments due to user
unawareness regarding connected healthcare systems and low adoption
rates of advanced technologies. Developing countries, such as
India, Bangladesh, Pakistan, and some African nations, have
underdeveloped healthcare facilities and a shortage of skilled
healthcare professionals, hindering early diagnosis and adoption of
smart inhalers. The use of sensors on traditional inhalers can
increase patient expenses, making advanced products less appealing
due to low disposable income and healthcare spending. These factors
collectively hinder the growth of the smart inhaler technology
market in developing countries.
- The Smart Inhaler Technology Market is experiencing significant
growth due to the rising prevalence of respiratory complications
from factors like tobacco smoke and air pollution. Technological
advancements in digital technology have led to the development of
smart inhalers, which are medical devices that transform manual
inhalers into digital devices. These devices collect clinical data,
including drug dosage and medicinal adherence, through sensors
and Bluetooth connectivity. The aging population base and
increasing healthcare expenditure have fueled demand for these
devices, particularly in highly polluted areas. Smart inhalers come
in two main types: DPI-based and MDI-based. DPI-based inhalers use
dry powder, while MDI-based inhalers use chemical propellants. Both
types offer dose monitoring mechanisms and dosing reminders to
improve treatment measures for acute respiratory diseases and
preventive care. E-commerce platforms have made these devices more
accessible, and their affordability caters to various disposable
incomes. Smart inhalers are essential for managing respiratory
ailments, reducing hospitalization, and lowering treatment
expenses. Despite their benefits, challenges remain, such as
inhalation capacity, multiple dose devices, and disease indication
specificity. Overall, smart inhalers are transforming respiratory
care, offering improved procedural outcomes and better disease
management.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This smart inhaler technology market report extensively covers
market segmentation by
- Product
- 1.1 Inhalers
- 1.2 Nebulizers
- Application
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Inhalers- Inhalers are essential medication devices
for managing COPD and asthma conditions. Patients require specific
inhalers based on their health status, available as Metered Dose
Inhalers (MDIs) or Dry Powder Inhalers (DPIs). MDIs, which are
short-acting bronchodilators, utilize pressurized drugs to
alleviate breathlessness. They can be used up to four times daily,
offering immediate relief for four to six hours. DPIs, long-acting
bronchodilators, employ dry, powdered drugs for inhalation with
full lung capacity. These inhalers provide relief for 12 to 24
hours and can be used once or twice daily. The escalating
prevalence of asthma and COPD drives the preference for inhalers as
the primary treatment. Smart inhalers offer remote consultations
through recorded data access, enabling physicians to prescribe
medications. Additionally, they monitor medication usage and
dosages, sending reminders for scheduled inhalation. These features
enhance respiratory care management for home-care patients and
non-critical COPD cases, contributing to the growth of the inhaler
segment and the market as a whole.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data (2017 -
2021) - Download a Sample Report
Research Analysis
Smart Inhaler Technology: Revolutionizing Asthma Management and
Chronic Respiratory Diseases Smart Inhaler Technology is
transforming the way we manage asthma and other chronic respiratory
diseases. Connected medical devices, such as Planet Innovation's
HeroTracker Sense, are integrating digital technology into metered
dose inhalers. These smart inhalers use sensors and Bluetooth
technology to connect with smartphones or digital devices, enabling
real-time monitoring of medication usage. Hospital pharmacies and
retail pharmacies are increasingly adopting this technology to
improve patient care and reduce hospital admissions and patient
visits due to respiratory complications. Telemedicine consultations
can now be more effective with patients' medication usage data at
the doctors' fingertips. In highly polluted areas, smart inhalers
can provide crucial information about air quality and offer alerts
to patients, helping them avoid triggers. Technological
advancements continue to drive innovation in this field, making
treatment more personalized and efficient.
Market Research Overview
The Smart Inhalers Market is experiencing significant growth due
to the increasing prevalence of chronic respiratory diseases such
as asthma and acute respiratory diseases. Connected medical
devices, including smart inhalers, are revolutionizing the way
respiratory ailments are managed. These devices, which include both
DPI-based and MDI-based models, use sensors and digital
technology to monitor inhalation capacity, dosage, and medication
adherence. Hospital pharmacies, retail pharmacies, and online
pharmacies are key distribution channels for smart inhalers. The
aging population base, tobacco smoke, and air pollution are major
factors driving the demand for these devices. Technological
advancements in digital technology, telemedicine, and clinical data
collection are also contributing to the market growth. Smart
inhalers are not limited to hospitals and home care settings but
are also used in highly polluted areas and other treatment
measures. Patients can use smartphones and digital devices to
monitor their medication intake, receive dosing reminders, and even
connect with healthcare providers via Bluetooth. The market for
smart inhalers is expected to grow due to the rising healthcare
expenditure, increasing disposable incomes, and the need for
preventive care. The market includes various types of inhalers,
such as manual inhalers, MDI-based inhalers, and DPI-based
inhalers, which use either dry powder or chemical propellant for
drug delivery. Despite the benefits of smart inhalers, challenges
such as procedural outcomes, hospital admissions, and treatment
expenses remain. However, the potential for improved patient
outcomes, reduced hospitalizations, and cost savings make smart
inhalers an essential tool in the management of respiratory
ailments.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Application
-
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/smart-inhaler-technology-market-size-is-set-to-grow-by-usd-46-37-million-from-2023-2027--rising-prevalence-of-respiratory-diseases-to-boost-the-market-growth-technavio-302209901.html
SOURCE Technavio